Bezan et al. and Lee et al. reported that this ratio can predict survival outcomes in patients with non-metastatic RCC and they found that an elevated AST/ALT ratio was significantly associated with inferior survival outcomes (14, 15). Here, GPT is linked to renal cell carcinoma.